{"transactions":[{"id":1430103,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-08-19T21:23:52.000Z","date":"2024-08-19","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":34.4904,"value":1724520.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $35.53, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (3) to this Form 4."}],"balance_after":2646972,"source":{"system":"sec-edgar","filing":"0000950170-24-098688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024098688/ownership.xml","form_type":"4"}},{"id":1430102,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-08-19T21:23:52.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":34.297,"value":1714850.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.84 to $34.86, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":2696972,"source":{"system":"sec-edgar","filing":"0000950170-24-098688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024098688/ownership.xml","form_type":"4"}},{"id":1430101,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-08-19T21:23:52.000Z","date":"2024-08-15","kind":"sale","planned":false,"acquired":false,"shares":39824,"price":33.0832,"value":1317505.3568,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $34.26, inclusive. The reporting person undertakes to provide to GeneDx Holding Corp. (the \"Company\"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":2746972,"source":{"system":"sec-edgar","filing":"0000950170-24-098688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024098688/ownership.xml","form_type":"4"}},{"id":1434113,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-08-14T20:50:25.000Z","date":"2024-08-13","kind":"sale","planned":false,"acquired":false,"shares":24987,"price":34.7582,"value":868503.1434,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.50 to $35.9175, inclusive. The reporting person undertakes to provide to Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":2786796,"source":{"system":"sec-edgar","filing":"0000950170-24-097135","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024097135/ownership.xml","form_type":"4"}},{"id":1434112,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-08-14T20:50:25.000Z","date":"2024-08-12","kind":"sale","planned":false,"acquired":false,"shares":59787,"price":33.9507,"value":2029810.5009,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.16 to $34.90, inclusive. The reporting person undertakes to provide to GeneDx Holding Corp. (the \"Company\"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":2811783,"source":{"system":"sec-edgar","filing":"0000950170-24-097135","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024097135/ownership.xml","form_type":"4"}},{"id":1438118,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-08-08T21:39:52.000Z","date":"2024-08-08","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":31.8238,"value":3182380.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.20 to $32.50, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":2871570,"source":{"system":"sec-edgar","filing":"0000950170-24-094224","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024094224/ownership.xml","form_type":"4"}},{"id":1438117,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-08-08T21:39:52.000Z","date":"2024-08-06","kind":"sale","planned":false,"acquired":false,"shares":12994,"price":29.3541,"value":381427.1754,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.75, inclusive. The reporting person undertakes to provide to GeneDx Holding Corp. (the \"Company\"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":2971570,"source":{"system":"sec-edgar","filing":"0000950170-24-094224","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024094224/ownership.xml","form_type":"4"}},{"id":1443475,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-08-02T20:21:51.000Z","date":"2024-07-31","kind":"sale","planned":false,"acquired":false,"shares":88839,"price":33.5027,"value":2976346.3653,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $34.21, inclusive. The reporting person undertakes to provide to GeneDx Holding Corp. (the \"Company\"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":2984564,"source":{"system":"sec-edgar","filing":"0000950170-24-089997","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024089997/ownership.xml","form_type":"4"}},{"id":1445622,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-07-31T21:03:04.000Z","date":"2024-07-29","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":33.8578,"value":1692890.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from 33.56 to $34.16, inclusive. The reporting person undertakes to provide to GeneDx Holding Corp. (the \"Company\"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":3073403,"source":{"system":"sec-edgar","filing":"0000950170-24-088679","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024088679/ownership.xml","form_type":"4"}},{"id":1448293,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-07-26T23:49:22.000Z","date":"2024-07-26","kind":"sale","planned":false,"acquired":false,"shares":60000,"price":33.8543,"value":2031258.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.50 to $34.66, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":3123403,"source":{"system":"sec-edgar","filing":"0000950170-24-087048","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024087048/ownership.xml","form_type":"4"}},{"id":1448292,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-07-26T23:49:22.000Z","date":"2024-07-24","kind":"sale","planned":false,"acquired":false,"shares":75000,"price":33.7214,"value":2529105.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.33 to $34.33, inclusive. The reporting person undertakes to provide to GeneDx Holding Corp. (the \"Company\"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":3183403,"source":{"system":"sec-edgar","filing":"0000950170-24-087048","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024087048/ownership.xml","form_type":"4"}},{"id":1450133,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-07-23T21:16:09.000Z","date":"2024-07-23","kind":"sale","planned":false,"acquired":false,"shares":75000,"price":33.4566,"value":2509245.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.72 to $34.50, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":3258403,"source":{"system":"sec-edgar","filing":"0000950170-24-085751","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024085751/ownership.xml","form_type":"4"}},{"id":1450132,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-07-23T21:16:09.000Z","date":"2024-07-22","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":32.6088,"value":1630440.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $33.02, inclusive. The reporting person undertakes to provide to GeneDx Holding Corp. (the \"Company\"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":3333403,"source":{"system":"sec-edgar","filing":"0000950170-24-085751","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024085751/ownership.xml","form_type":"4"}},{"id":1450131,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-07-23T21:16:09.000Z","date":"2024-07-19","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":32.29,"value":807250.0,"ownership":{"direct":true},"balance_after":3383403,"source":{"system":"sec-edgar","filing":"0000950170-24-085751","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024085751/ownership.xml","form_type":"4"}},{"id":1451442,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-07-19T22:46:15.000Z","date":"2024-07-17","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":32.9275,"value":823187.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.87 to $33.18, inclusive. The reporting person undertakes to provide to GeneDx Holding Corp. (the \"Company\"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":3408403,"source":{"system":"sec-edgar","filing":"0000950170-24-085008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024085008/ownership.xml","form_type":"4"}},{"id":1457852,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-07-09T20:07:09.000Z","date":"2024-07-05","kind":"sale","planned":false,"acquired":false,"shares":36118,"price":28.2412,"value":1020015.6616,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.75, inclusive. The reporting person undertakes to provide to GeneDx Holdings Corp. (the \"Company\"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":3433403,"source":{"system":"sec-edgar","filing":"0000950170-24-082411","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024082411/ownership.xml","form_type":"4"}},{"id":1460956,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-07-03T20:56:52.000Z","date":"2024-07-03","kind":"sale","planned":true,"acquired":false,"shares":14082,"price":28.2269,"value":397491.2058,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.965, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (3) to this Form 4."}],"balance_after":3469521,"source":{"system":"sec-edgar","filing":"0000950170-24-081596","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024081596/ownership.xml","form_type":"4"}},{"id":1460955,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-07-03T20:56:52.000Z","date":"2024-07-02","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":29.1238,"value":728095.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.31 to $31.20, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":3483603,"source":{"system":"sec-edgar","filing":"0000950170-24-081596","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024081596/ownership.xml","form_type":"4"}},{"id":1460954,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-07-03T20:56:52.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":26.634,"value":1331700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.4607 to $26.95, inclusive. The reporting person undertakes to provide to GeneDx Holding Corp. (the \"Company\"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":3508603,"source":{"system":"sec-edgar","filing":"0000950170-24-081596","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024081596/ownership.xml","form_type":"4"}},{"id":1920534,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-13T20:46:44.000Z","date":"2023-04-11","kind":"grant","planned":false,"acquired":true,"shares":23148148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is receiving these shares as payment for having achieved a milestone event as described in the Agreement and Plan of Merger and Reorganization, dated January 14, 2022, to which the Reporting Person and the Issuer are parties."}],"balance_after":117433862,"source":{"system":"sec-edgar","filing":"0001209191-23-024222","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123024222/doc4.xml","form_type":"4"}},{"id":2040717,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"OPKO HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-01T01:01:06.000Z","date":"2023-01-26","kind":"purchase","acquired":true,"shares":14285714,"price":0.35,"value":4999999.9,"ownership":{"direct":true},"balance_after":94285714,"source":{"system":"sec-edgar","filing":"0001209191-23-005821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123005821/doc4.xml","form_type":"4"}},{"id":4124208,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"Opko Health, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-21T23:27:47.000Z","date":"2017-12-19","kind":"grant","acquired":true,"shares":495126,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 19, 2017, the Issuer, Sevion Sub Ltd. (\"Acquisition Sub\"), and Eloxx Pharmaceuticals Ltd. (\"Eloxx\"), completed the merger contemplated under that certain Merger Agreement dated May 31, 2017, and pursuant to which Acquisition Sub merged with and into Eloxx, with Eloxx becoming the surviving corporation and a wholly-owned subsidiary of the Issuer. At the effective time of the merger, shares held by existing Eloxx shareholders prior to the Merger was converted, on a pro rata basis, into the right to receive 20,316,656 shares of Issuer common stock, after giving effect to a 1-for-20 reverse stock split that was effected on December 19, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 19, 2017, the Issuer, Sevion Sub Ltd. (\"Acquisition Sub\"), and Eloxx Pharmaceuticals Ltd. (\"Eloxx\"), completed the merger contemplated under that certain Merger Agreement dated May 31, 2017, and pursuant to which Acquisition Sub merged with and into Eloxx, with Eloxx becoming the surviving corporation and a wholly-owned subsidiary of the Issuer. At the effective time of the merger, shares held by existing Eloxx shareholders prior to the Merger was converted, on a pro rata basis, into the right to receive 20,316,656 shares of Issuer common stock, after giving effect to a 1-for-20 reverse stock split that was effected on December 19, 2017."}],"balance_after":1289818,"source":{"system":"sec-edgar","filing":"0001209191-17-066864","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117066864/doc4.xml","form_type":"4"}},{"id":4170566,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"Opko Health, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"0% Series C Convertible Perferred","published_at":"2017-11-07T21:00:46.000Z","date":"2017-09-19","kind":"exercise","acquired":false,"shares":66667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The derivative security was previously subject to a \"blocker\" pursuant to which the reporting person was unable to convert the derivative security to the extent such conversion would result in the reporting person owning more than 4.99%."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The convertible preferred stock was convertible at any time at the holder's option and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The convertible preferred stock was convertible at any time at the holder's option and had no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0.4,"underlying":"Common Stock","underlying_shares":1250006},"source":{"system":"sec-edgar","filing":"0001209191-17-059592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117059592/doc4.xml","form_type":"4"}},{"id":4170565,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"Opko Health, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-07T21:00:46.000Z","date":"2017-09-19","kind":"exercise","acquired":true,"shares":1250006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person converted 66,667 shares of 0% Series C Convertible Preferred Stock on September 19, 2017 at a conversion price of $.40 per share, resulting in the acquisition of 1,250,006 shares of Common Stock.  The conversion was effected in connection with that certain proposed merger between the Issuer, Sevion Sub Ltd. (\"Acquisition Sub\"), and Eloxx Pharmaceuticals Ltd. (\"Eloxx\"), pursuant to which, subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement dated May 31, 2017, Acquisition Sub will merge with and into Eloxx, with Eloxx becoming the surviving corporation and a wholly-owned subsidiary of the Issuer."}],"balance_after":15893844,"source":{"system":"sec-edgar","filing":"0001209191-17-059592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117059592/doc4.xml","form_type":"4"}},{"id":4177097,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"Opko Health, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-01T16:11:50.000Z","date":"2017-10-30","kind":"purchase","acquired":true,"shares":655738,"price":3.05,"value":2000000.9,"ownership":{"direct":true},"balance_after":6678752,"source":{"system":"sec-edgar","filing":"0001209191-17-058591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000120919117058591/doc4.xml","form_type":"4"}},{"id":4235621,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"Opko Health, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2017-08-14T21:15:34.000Z","date":"2017-08-10","kind":"exercise","acquired":false,"price":0,"reported_value":250000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The derivative security was previously subject to a \"blocker\" pursuant to which the reporting person was unable to convert the derivative security to the extent such conversion would result in the reporting person owning more than 4.99%."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of the Convertible Note, the Reporting Person acquired (i) 2,500,000 shares of Common Stock upon conversion of $250,000 in principal amount of the Convertible Note, and (ii) 63,699 shares of Common Stock in accrued and previously unpaid interest thereon (6,369.86)."}],"balance_after":0,"derivative":{"exercise_price":0.1,"exercise_date":"2017-02-24","expiration_date":"2017-08-24","underlying":"Common Stock","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0001209191-17-048791","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117048791/doc4.xml","form_type":"4"}},{"id":4235620,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"Opko Health, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2017-08-14T21:15:34.000Z","date":"2017-08-10","kind":"exercise","acquired":false,"price":0,"reported_value":150000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The derivative security was previously subject to a \"blocker\" pursuant to which the reporting person was unable to convert the derivative security to the extent such conversion would result in the reporting person owning more than 4.99%."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the Convertible Note, the Reporting Person acquired (i) 1,500,000 shares of Common Stock upon conversion of $150,000 in principal amount of the Convertible Note, and (ii) 63,123 shares of Common Stock in accrued and previously unpaid interest thereon ($6,312.33)."}],"balance_after":0,"derivative":{"exercise_price":0.1,"exercise_date":"2016-11-10","expiration_date":"2017-11-10","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001209191-17-048791","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117048791/doc4.xml","form_type":"4"}},{"id":4235619,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"Opko Health, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-08-14T21:15:34.000Z","date":"2017-08-10","kind":"exercise","acquired":true,"shares":2563699,"price":0.1,"value":256369.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of the Convertible Note, the Reporting Person acquired (i) 2,500,000 shares of Common Stock upon conversion of $250,000 in principal amount of the Convertible Note, and (ii) 63,699 shares of Common Stock in accrued and previously unpaid interest thereon (6,369.86)."}],"balance_after":14643838,"source":{"system":"sec-edgar","filing":"0001209191-17-048791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117048791/doc4.xml","form_type":"4"}},{"id":4235618,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC.","position":1,"cik":"0000944809","reported_name":"Opko Health, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-08-14T21:15:34.000Z","date":"2017-08-10","kind":"exercise","acquired":true,"shares":1563123,"price":0.1,"value":156312.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the Convertible Note, the Reporting Person acquired (i) 1,500,000 shares of Common Stock upon conversion of $150,000 in principal amount of the Convertible Note, and (ii) 63,123 shares of Common Stock in accrued and previously unpaid interest thereon ($6,312.33)."}],"balance_after":12080139,"source":{"system":"sec-edgar","filing":"0001209191-17-048791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117048791/doc4.xml","form_type":"4"}}]}